CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells

Cisplatin (cis-diamminedichloroplatinum II [CDDP] ) is a well-known chemotherapeutic drug that has been used for the treatment of various types of human cancers, including head and neck cancer. Cisplatin exerts anticancer effects by causing DNA damage, replication defects, transcriptional inhibition...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Chikuda, Junichiro, Otsuka, Kurataka, Shimomura, Iwao, Ito, Kagenori, Miyazaki, Hiroaki, Takahashi, Ryou-u, Nagasaki, Masahiro, Mukudai, Yoshiki, Ochiya, Takahiro, Shimane, Toshikazu, Shirota, Tatsuo, Yamamoto, Yusuke
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226407/
https://ncbi.nlm.nih.gov/pubmed/32244823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12040856
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados